Please login to the form below
UK Vaccine Taskforce
This page shows the latest UK Vaccine Taskforce news and features for those working in and with pharma, biotech and healthcare.
Moderna to launch Innovation and Technology Center in the UK
Stéphane Bancel, chief executive officer of Moderna, said: "We are excited to be able to continue our collaboration with the UK government and Vaccine Taskforce with this new mRNA Innovation and ... The company also intends to further expand its UK
Latest news
-
J&J's single-dose COVID-19 vaccine secures approval from the UK’s MHRA
Johnson &Johnson’s (J&J) single-dose COVID-19 vaccine has secured authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), the regulator announced today. ... Although the UK Vaccine Taskforce originally secured 30
-
AZ’s COVID-19 vaccine proves promising in elderly participants, new data shows
The government’s Vaccine Taskforce is pursuing a portfolio approach to obtaining vaccines for the UK across different vaccine formats, to maximise the chances of finding safe and effective vaccines,” said ... Kate Bingham, chair of the government’s
-
UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’
The head of the UK Vaccine Taskforce Kate Bingham said on Wednesday that the first vaccines for COVID-19 are ‘likely to be imperfect’. ... If these candidates prove effective in large-scale phase 3 trials, the UK’s Vaccine Taskforce has options to
-
Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses
The UK Vaccine Taskforce has partnered with Oxford Immunotec to supply T cell testing for its assessment of potential COVID-19 vaccine candidates. ... The UK Vaccines Taskforce is currently including T cell analysis in COVID-19 vaccine trials, as it is
-
J&J advances COVID-19 vaccine into phase 3 testing
Last week, Novavax also announced the launch of its first phase 3 COVID-19 vaccine trial in the UK. ... The study is being conducted in partnership with the UK government’s Vaccine Taskforce, and will evaluate the efficacy, safety and immunogenicity of
More from news
Approximately 1 fully matching, plus 6 partially matching documents found.
Latest appointments
-
Virtual agency The Difference Collective makes new hires to senior team
Six senior healthcare communications consultants join the company's ranks. UK-based virtual agency The Difference Collective has announced new hires to its senior team, with six senior healthcare communications consultants ... Hornby has led
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
What does the COVID-19 vaccine mean for the future of R&D?
In 2009, the development of an H1N1 vaccine utilised existing flu vaccine technology. ... The European Commission and the UK Government Vaccine Taskforce have also been significant contributors to a wide variety of vaccine projects.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- A new era for UK-Japanese scientific research relations
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Realising the potential of omnichannel in medical communications
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- AI is transforming pharma R&D – now it can transform pharma marketing
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Six UK universities receive grant for research into motor neurone disease
- My journey advancing the science in pulmonary hypertension
PMHub
Langland
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
